These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25087921)

  • 1. From skin to other cell types of the body.
    Novak D; Weina K; Utikal J
    J Dtsch Dermatol Ges; 2014 Sep; 12(9):789-92. PubMed ID: 25087921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From skin to the treatment of diseases--the possibilities of iPS cell research in dermatology.
    Galach M; Utikal J
    Exp Dermatol; 2011 Jun; 20(6):523-8. PubMed ID: 21585557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanin Transfer in Human 3D Skin Equivalents Generated Exclusively from Induced Pluripotent Stem Cells.
    Gledhill K; Guo Z; Umegaki-Arao N; Higgins CA; Itoh M; Christiano AM
    PLoS One; 2015; 10(8):e0136713. PubMed ID: 26308443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reprogramming of somatic cells. Problems and solutions].
    Schneider TA; Fishman VS; Liskovykh MA; Ponamartsev SV; Serov OL; Tomilin AN; Alenina N
    Tsitologiia; 2014; 56(12):869-80. PubMed ID: 25929128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential of human induced pluripotent stem cells for modelling diabetic wound healing
    Martin PE; O'Shaughnessy EM; Wright CS; Graham A
    Clin Sci (Lond); 2018 Aug; 132(15):1629-1643. PubMed ID: 30108152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat embryonic fibroblasts improve reprogramming of human keratinocytes into induced pluripotent stem cells.
    Linta L; Stockmann M; Kleinhans KN; Böckers A; Storch A; Zaehres H; Lin Q; Barbi G; Böckers TM; Kleger A; Liebau S
    Stem Cells Dev; 2012 Apr; 21(6):965-76. PubMed ID: 21699413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concise review: harmonies played by microRNAs in cell fate reprogramming.
    Moradi S; Asgari S; Baharvand H
    Stem Cells; 2014 Jan; 32(1):3-15. PubMed ID: 24155164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming of Keratinocytes as Donor or Target Cells Holds Great Promise for Cell Therapy and Regenerative Medicine.
    Zhang Y; Hu W; Ma K; Zhang C; Fu X
    Stem Cell Rev Rep; 2019 Oct; 15(5):680-689. PubMed ID: 31197578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De- and re-differentiation of the melanocytic lineage.
    Larribere L; Utikal J
    Eur J Cell Biol; 2014; 93(1-2):30-5. PubMed ID: 24365127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction of tissue engineering skin containing melanocytes].
    Liu Y; Jin Y; Wang XW
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 Nov; 17(6):501-3. PubMed ID: 14663953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using human hair follicle-derived keratinocytes and melanocytes for constructing pigmented tissue-engineered skin.
    Liu F; Luo XS; Shen HY; Dong JS; Yang J
    Skin Res Technol; 2011 Aug; 17(3):373-9. PubMed ID: 21332809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering cell fate: Spotlight on cell-activation and signaling-directed lineage conversion.
    Ebrahimi B
    Tissue Cell; 2016 Oct; 48(5):475-87. PubMed ID: 27514850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of 3D Skin Organoid from Cord Blood-derived Induced Pluripotent Stem Cells.
    Kim Y; Ju JH
    J Vis Exp; 2019 Apr; (146):. PubMed ID: 31058887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Building a microphysiological skin model from induced pluripotent stem cells.
    Guo Z; Higgins CA; Gillette BM; Itoh M; Umegaki N; Gledhill K; Sia SK; Christiano AM
    Stem Cell Res Ther; 2013; 4 Suppl 1(Suppl 1):S2. PubMed ID: 24564920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells.
    Itoh M; Kiuru M; Cairo MS; Christiano AM
    Proc Natl Acad Sci U S A; 2011 May; 108(21):8797-802. PubMed ID: 21555586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress in induced pluripotent stem cell research for age-related neurodegenerative diseases].
    Ito D; Yagi T; Suzuki N
    Brain Nerve; 2013 Mar; 65(3):283-8. PubMed ID: 23475520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of germ cells in vitro in the era of induced pluripotent stem cells.
    Imamura M; Hikabe O; Lin ZY; Okano H
    Mol Reprod Dev; 2014 Jan; 81(1):2-19. PubMed ID: 23996404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress made in the reprogramming field: new factors, new strategies and a new outlook.
    Hussein SM; Nagy AA
    Curr Opin Genet Dev; 2012 Oct; 22(5):435-43. PubMed ID: 22959308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can controlled cellular reprogramming be achieved using microRNAs?
    Sun X; Fu X; Han W; Zhao Y; Liu H
    Ageing Res Rev; 2010 Oct; 9(4):475-83. PubMed ID: 20601195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonviral delivery for reprogramming to pluripotency and differentiation.
    Park HJ; Shin J; Kim J; Cho SW
    Arch Pharm Res; 2014 Jan; 37(1):107-19. PubMed ID: 24222505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.